205 related articles for article (PubMed ID: 33728572)
21. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.
Sperry BW; Reyes BA; Ikram A; Donnelly JP; Phelan D; Jaber WA; Shapiro D; Evans PJ; Maschke S; Kilpatrick SE; Tan CD; Rodriguez ER; Monteiro C; Tang WHW; Kelly JW; Seitz WH; Hanna M
J Am Coll Cardiol; 2018 Oct; 72(17):2040-2050. PubMed ID: 30336828
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study.
Vianello PF; La Malfa G; Tini G; Mazzola V; Miceli A; Santolini E; Briano S; Porto I; Canepa M
Int J Cardiol; 2021 Apr; 329():144-147. PubMed ID: 33358831
[TBL] [Abstract][Full Text] [Related]
23. Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.
Ng QKT; Sethi P; Saunders TA; Pampaloni MH; Flavell RR
Clin Nucl Med; 2018 Mar; 43(3):e89-e92. PubMed ID: 29261619
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy.
Nitsche C; Mascherbauer K; Calabretta R; Koschutnik M; Dona C; Dannenberg V; Hofer F; Halavina K; Kammerlander AA; Traub-Weidinger T; Goliasch G; Hengstenberg C; Hacker M; Mascherbauer J
J Nucl Med; 2022 Dec; 63(12):1906-1911. PubMed ID: 35710734
[TBL] [Abstract][Full Text] [Related]
25. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
Waheed A; Dorbala S
Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
[TBL] [Abstract][Full Text] [Related]
26. Cardiac [
Tingen HSA; Tubben A; Bijzet J; van den Berg MP; van der Meer P; Houwerzijl EJ; Muntinghe FLH; van der Zwaag PA; Glaudemans AWJM; Oerlemans MIFJ; Knackstedt C; Michels M; Hirsch A; Hazenberg BPC; Slart RHJA; Nienhuis HLA
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):681-690. PubMed ID: 37843599
[TBL] [Abstract][Full Text] [Related]
27. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
[TBL] [Abstract][Full Text] [Related]
28. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
[TBL] [Abstract][Full Text] [Related]
29. Spleen visualization in both TTR and AL amyloidosis during
Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
[TBL] [Abstract][Full Text] [Related]
30. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
31. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
32. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
[TBL] [Abstract][Full Text] [Related]
33. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
[TBL] [Abstract][Full Text] [Related]
34. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
35. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
36. Incidental cardiac uptake of
Salvalaggio A; Cipriani A; Righetto S; Artioli P; Sinigiani G; De Michieli L; Cason M; Pilichou K; Cecchin D; Briani C
J Nucl Cardiol; 2022 Dec; 29(6):3419-3425. PubMed ID: 35437680
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis.
Asif T; Araujo T; Singh V; Malhotra S
J Nucl Cardiol; 2020 Jun; 27(3):1044-1046. PubMed ID: 32185683
[No Abstract] [Full Text] [Related]
38. Isolated cardiac amyloidosis. Utility of bone seeking tracers scintigraphy in differentiating the subtype of amyloid: A case report.
Bourogianni O; Papadaki E; Foukarakis E; Koukouraki S
J Nucl Cardiol; 2019 Feb; 26(1):337-341. PubMed ID: 29476454
[TBL] [Abstract][Full Text] [Related]
39. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
40.
Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
